Autoantibodies in breast cancer: Their use as an aid to early diagnosis

Annals of Oncology

Volumn 18, Issue 5, 2007, Pages 868-873

  Chapman, Caroline ^a,b   Murray, A ^b   Chakrabarti, J ^a   Thorpe, A ^a   Woolston, C ^a   Sahin, U ^c   Barnes, A ^b   Robertson, J ^a,b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Antigen; Autoantibodies; Bbreast cancer; Diagnosis; Immunologic tests; Tumour markers

Indexed keywords

AUTOANTIBODY; BRCA1 PROTEIN; BRCA2 PROTEIN; MUCIN 1; MYC PROTEIN; NY ESO 1 ANTIGEN; PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER RISK; CANCER SIZE; CARCINOMA IN SITU; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EARLY CANCER; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

EID: 34447299418     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm007     Document Type: Article

References (20)

1. Althuis MD, Dozier JM, Anderson WF et al. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol 2005; 34: 405-412.
2. Griffiths C, Brock A. Twentieth century mortality trends in England and Wales. Office for National Statistics. Health Stat Q 2003; 18: 5-17.
3. Jensen AR, Garne JP, Storm HH et al. Stage and survival in breast cancer patients in screened and non-screened Danish and Swedish populations. Acta Oncol 2003; 42: 701-709.
4. Vainio BF (ed). IARC Handbooks of Cancer Prevention: Breast Cancer Screening, Vol 7. Lyon, France: IARC Press 2002.
5. Molina R, Barak V, van Dalen A et al. Tumor markers in breast cancer - European Group on tumor markers recommendations. Tumor Biol 2005; 26: 281-293.
6. Robertson JFR, Graves RL, Price MR, Inventors; OncImmune Ltd, assignee. Tumour markers. European patent EP-B 1078264. 2005.
7. Sambrook J, Fritsch EF, Mariatis T. Molecular Cloning a Laboratory Manual, 2nd edition. Plainview, NY: Cold Spring Harbour Laboratory Press 1989.
8. Gendler SJ, Spicer AP, Lalani EN et al. Structure and biology of the carcinoma-associated mucin, MUC1. Am Rev Resp Dis 1991; 144: S42-S47.
9. Haybittle JL, Elston CW, Johnson J et al. A prognostic index in primary breast-cancer. Br J Cancer 1982; 45: 361-366.
10. Storr SJ, Chakrabarti J, Barnes A et al. Use of autoantibodies in breast cancer screening and diagnosis. Expert Rev Anticancer Ther 2006; 6: 1215-1223.
11. Elmore JG, Miglioretti DL, Reisch LM, et al. Screening Mammograms by community radiologists: Variability in false positive rates. J Natl Cancer Inst 2002; 94: 1373-1380.
12. Robertson JFR, Chapman C, Cheung K-L et al. Autoantibodies in early breast cancer. J Clin Oncol 2005; 23: 549.
13. Robertson JFR. Serum autoantibody profile test for early cancer detection. Presentation at tumor markers for personalised medicine: The New Frontier, MD Anderson Cancer Centre meeting, Hawaii, 2006.
14. Zhang JY, Casiano CA, Peng XX et al. Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens. Cancer Epidemiol Biomarkers Prev. 2003; 12 (2): 136-143.
15. Yagihashi A, Ohmura T, Asanuma K et al. Detection of autoantibodies to survivin and livin in sera from patients with breast cancer. Clin Chim Acta 2005; 362: 125-130.
16. Nesterova M, Johnson N, Cheadle C, Cho-Chung YS. Autoantibody biomarker opens a new gateway for cancer diagnosis. Biochimica et Biophysica Acta 2006; 1762: 398-403.
17. Gottschlich S, Hoffmann M, Maass JD et al. p53 autoantibodies as tumor marker in head and neck squamous cell cancer. Anticancer Res 2003; 23: 913-915.
18. Türeci O, Mack U, Luxemberger U et al. Humoral responses of lung cancer patients against tumor antigen NY-ESO-1. Cancer Lett 2006; 236: 64-71.
19. Schmetzer O, Moldenhauer G, Riesenberg R et al. Quality of recombinant protein determines the amount of autoreactivity detected against the tumor-associated epithelial cell adhesion molecule antigen: Low frequency of antibodies against the natural protein. J Immunol 2005; 174: 942-952.
20. Lehman CD, Schnall MD. Imaging in breast cancer: Magnetic resonance imaging. Breast Cancer Res 2005; 7: 215-219.